InspireMD (NSPR) Gross Profit Growth (1y) (2011 - 2025)
InspireMD (NSPR) Gross Profit Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Profit Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 15.59% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | 17.10% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 10.88% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 12.38% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 13.54% |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | 20.50% |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 9.82% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 4.20% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 8.95% |
| 10 | InspireMD | 58.53 Mn | 4.32 Mn | 1.18 Mn | 151.60% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 151.60% |
| Sep 30, 2025 | 108.70% |
| Jun 30, 2025 | -5.44% |
| Mar 31, 2025 | 0.00% |
| Dec 31, 2024 | -7.13% |
| Sep 30, 2024 | -5.48% |
| Jun 30, 2024 | -32.59% |
| Mar 31, 2024 | -21.72% |
| Dec 31, 2023 | 155.05% |
| Sep 30, 2023 | 19.67% |
| Jun 30, 2023 | 13.92% |
| Mar 31, 2023 | 205.74% |
| Dec 31, 2022 | -32.65% |
| Sep 30, 2022 | 297.83% |
| Jun 30, 2022 | 64.50% |
| Mar 31, 2022 | 15.09% |
| Dec 31, 2021 | 175.38% |
| Sep 30, 2021 | -69.13% |
| Jun 30, 2021 | 318.33% |
| Mar 31, 2021 | -64.07% |